CrushSCI.com
37.8Average days
33.5Median days
13Fastest days
104Longest days
5082025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

30 days

Colchicine Use Is Associated with Shorter ICU Stay and Lower FFP Transfusion Requirements After CABG

Authors
Mehmet Burak Gulcan; Mehmet Ali Kaygın; Aycan Mutlu Yaganoglu; Ziya Yıldız; Abdulselam Karaduman; Suleyman Aycan; Ozgur DagShow moreShow less
Affiliations
1. Department of Cardiovascular Surgery, Ankara Yıldırım Beyazıt University Yenimahalle Training and Research Hospital, 06370 Ankara, Türkiye; 2. Department of Cardiovascular Surgery, Erzurum City Hospital, 25240 Erzurum, Türkiye; 3. Department of Zootechnics, Faculty of Agriculture, Ataturk University , 25240 Erzurum, Türkiye; 4. Department of Congenital Cardiovascular Surgery, Mehmet Akif Ersoy Chest and Cardiovascular Surgery Research and Training Hospital, 34303 Istanbul, TürkiyeShow moreShow less
Source PDF DOI Publisher page
104 days

Development and Population-Based Prognostic Utility Assessment of an ICD-10-CM-Based Prediction Model to Identify Left Ventricular Systolic Dysfunction: Discrimination Performance and Population-Based Evaluation in 83,357 Patients with Acute Coronary Syndrome

Authors
Andreea Eunice Cosa; Marc Llagostera Martin; Sílvia Jovells-Vaqué; Mireia Andrés-Villareal; Emili Vela; Júlia Folguera Profitós; David Monterde; Jordi Piera-Jiménez; Gerard Carot-Sans; Raúl Ramos-Polo; Oona Meroño; Adrià Ricarte Marín; Natalia López Fernández; Albert Ariza-Solé; Cristina Enjuanes; Josep Comín-ColetShow moreShow less
Affiliations
1. Bio-Heart Cardiovascular Diseases Research Group, https://ror.org/0008xqs48Bellvitge Biomedical Research Institute (IDIBELL), 08907 Barcelona, Spain; aeunice@idibell.cat (A.E.C.); sjovells@idibell.cat (S.J.-V.); mireia.andres.idi@gencat.cat (M.A.-V.); rramosp@bellvitgehospital.cat (R.R.-P.); cenjuanes@bellvitgehospital.cat (C.E.); 2. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto Salud Carlos III, 28029 Madrid, Spain; 3. Cardiology Department, Heart Institute, https://ror.org/00epner96Bellvitge University Hospital, 08907 Barcelona, Spain; mllagosteram@bellvitgehospital.cat (M.L.M.); omerono@bellvitgehospital.cat (O.M.); aariza@bellvitgehospital.cat (A.A.-S.); 4. Gerència d’Atenció Primària i Comunitària (GAPiC) Delta and Penedès, Catalan Health Institute, 08907 Barcelona, Spain; 5. Medicine Department, School of Medicine, https://ror.org/00tse2b39International University of Catalonia, 08195 Barcelona, Spain; 6. Health Information System Department, Catalan Health Service, 08007 Barcelona, Spain; evela@catsalut.cat (E.V.); julia.folguera@catsalut.cat (J.F.P.); gerard.carot@catsalut.cat (G.C.-S.); 7. Digitalization for the Sustainability of the Healthcare System (DS3), 08006 Barcelona, Spain; dmonterde@gencat.cat (D.M.); jpiera@catsalut.cat (J.P.-J.); 8. Health Information System Department, Catalan Institute of Health, 08007 Barcelona, Spain; 9. Fundació TIC Salut i Social, 08009 Barcelona, Spain; 10. Community Heart Failure Program, Cardiology Department, https://ror.org/00epner96Bellvitge University Hospital, 08907 Barcelona, Spain; 11. Functional Data Management Unit, https://ror.org/00epner96Bellvitge University Hospital, 08907 Barcelona, Spain; aricarte@bellvitgehospital.cat (A.R.M.); natalialopez@bellvitgehospital.cat (N.L.F.); 12. Department of Clinical Sciences, School of Medicine, Universitat de Barcelona, 08907 Barcelona, SpainShow moreShow less
Official full-text evidence DOI Publisher page
37 days

Coexisting Moderate-to-Severe Tricuspid Regurgitation and Renal Dysfunction Identify a High-Risk Group After Transcatheter Aortic Valve Replacement

Authors
Philipp Lauten; Birgit Markus; Georgios Chatzis; Styliani Syntila; Bernhard Schieffer; Klevis Mihali; Julian KreutzShow moreShow less
Affiliations
1. Department of Cardiology, Angiology, and Intensive Care Medicine, Philipps-Universität Marburg, Baldingerstraße, 35043 Marburg, Germany; 2. Department of Cardiology, Heart Center, Central Hospital of Bad Berka, 99437 Bad Berka, GermanyShow moreShow less
Official full-text evidence DOI Publisher page
45 days

Recurrence Rates and Outcomes After First Detected Atrial Fibrillation Episode in a Contemporary Hypertrophic Cardiomyopathy Center

Authors
Mauro Rogerio de Barros Wanderley; Martin S. Maron; Jonathan S. Silver; Paul Harnish; Bruce G. Hook; Ethan J. RowinShow moreShow less
Affiliations
1. Internal Medicine Department, https://ror.org/03mbq3y29Lahey Hospital and Medical Center, Burlington, MA 01803, USA; mdebarr2@lahey.org; 2. Hypertrophic Cardiomyopathy Center, https://ror.org/03mbq3y29Lahey Hospital and Medical Center, Burlington, MA 01803, USA; 3. Department of Electrophysiology, https://ror.org/03mbq3y29Lahey Hospital and Medical Center, Burlington, MA 01803, USAShow moreShow less
Official full-text evidence DOI Publisher page
27 days

Machine Learning-Based Prediction of Long-Term Mortality in Patients with Implantable Cardioverter Defibrillators

Authors
Lei Pan; Zilong Xiao; Ziqing Yu; Siyuan Li; Weiwei Zhang; Ruogu Li; Zhongkai Wang; Hongyang Lu; Wei Hua; Yangang Su; Yixiu LiangShow moreShow less
Affiliations
1. Department of Cardiology, https://ror.org/032x22645Zhongshan Hospital of Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Centre for Interventional Medicine, Shanghai 200032, China; panleiyaomingkaka@126.com (L.P.); xiao1453497595@163.com (Z.X.); yu.ziqing@zs-hospital.sh.cn (Z.Y.);; 2. Shanghai Medical College, https://ror.org/013q1eq08Fudan University, Shanghai 200032, China; lisiyuan24@m.fudan.edu.cn; 3. Department of Cardiology, Shanghai Chest Hospital of https://ror.org/0220qvk04Shanghai Jiao Tong University, Shanghai 200030, China; zww1230523@163.com (W.Z.); liruogu@hotmail.com (R.L.); 4. Department of Cardiology, https://ror.org/02bjs0p66Changhai Hospital, Naval Medical University, Shanghai 200433, China; 13816038626@163.com; 5. Cardiac Rhythm Management, Medtronic Technology Center, Medtronic (Shanghai) Ltd., Shanghai 201203, China; 6. State Key Laboratory of Cardiovascular Disease, Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Disease, https://ror.org/02drdmm93Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China; drhuaweifw@sina.comShow moreShow less
Official full-text evidence DOI Publisher page
14 days

Preoperative Advanced Lung Cancer Inflammation Index and Acute Kidney Injury After Adult Cardiac Surgery: A Retrospective Cohort Study

Authors
Haoran Gan; Ruoyu Zhang; Rui Fan; Li Yin; Shengjie Ning; Junzhe Wang; Dongming Liu; Wen Chen; Xin Chen; Zhibing QiuShow moreShow less
Affiliations
1. Department of Thoracic and Cardiovascular Surgery, Nanjing First Hospital, Nanjing University of Chinese Medicine, Nanjing 210006, China; 2. Department of Thoracic and Cardiovascular Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, ChinaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Journal of Cardiovascular Development and Disease take to review a manuscript?

As of 2026-11-19, CrushSCI has 10 complete review records for Journal of Cardiovascular Development and Disease. The fastest paper went from submission to acceptance in 13 days (Evaluation of Clinical SYNTAX Score in Predicting New-Onset Atrial Fibrillation and Long-Term Prognosis in Patients Hospitalized with Non-ST Segment Elevation Myocardial Infarction, received 2026-09-14, accepted 2026-09-27); the slowest took 104 days. The average is 37.8 days and the median is 33.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.